Luis Ruilope Selected Research

Luis Ruilope Research Topics

Disease

21	Hypertension (High Blood Pressure) 12/2023 - 01/2000
5	Heart Failure 04/2017 - 01/2000
4	Chronic Renal Insufficiency 01/2022 - 08/2013
4	Type 2 Diabetes Mellitus (MODY) 01/2022 - 05/2003
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 03/2002
2	Stroke (Strokes) 11/2022 - 01/2003
2	Inflammation (Inflammations) 01/2022 - 03/2002
2	Kidney Diseases (Kidney Disease) 12/2019 - 01/2017
2	Proteinuria 12/2019 - 01/2018
2	Albuminuria 01/2019 - 05/2003
2	Chronic Kidney Failure (Chronic Renal Failure) 04/2017 - 01/2017
1	Myocardial Infarction 11/2022
1	Disease Progression 01/2022
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022
1	Renal Insufficiency (Renal Failure) 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Hyperkalemia 12/2019
1	Obstructive Sleep Apnea 01/2017
1	Sleep Apnea Syndromes (Sleep Apnea) 01/2017
1	Hypoglycemia (Reactive Hypoglycemia) 07/2015
1	Prediabetic State (Prediabetes) 07/2015
1	Glucose Intolerance 08/2013
1	Isolated Systolic Hypertension 01/2004
1	Coronary Disease (Coronary Heart Disease) 01/2003
1	Cough 01/2003
1	Vascular Remodeling 03/2002
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2000

Drug/Important Bio-Agent (IBA)

7	Antihypertensive Agents (Antihypertensives)IBA 01/2019 - 05/2002
4	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2019 - 01/2000
3	Perindopril FDA LinkGeneric 02/2015 - 05/2003
2	Mineralocorticoid Receptor AntagonistsIBA 12/2019 - 01/2019
2	Angiotensin Receptor AntagonistsIBA 12/2019 - 01/2019
2	AngiotensinsIBA 04/2017 - 01/2017
2	AldosteroneIBA 04/2017 - 01/2017
2	SodiumIBA 04/2017 - 01/2017
2	ReninIBA 04/2017 - 01/2017
2	Edetic Acid (EDTA)FDA Link 04/2017 - 01/2017
2	Erythropoietin FDA Link 04/2017 - 01/2017
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 07/2015 - 11/2014
2	aleglitazarIBA 07/2015 - 11/2014
2	olmesartanIBA 02/2015 - 12/2013
2	Amlodipine (Norvasc)FDA LinkGeneric 02/2015 - 12/2013
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 05/2002 - 03/2002
1	salicylhydroxamic acid (SHAM)IBA 12/2023
1	antineoplaston A10 (A 10)IBA 11/2022
1	finerenoneIBA 01/2022
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2022
1	CreatinineIBA 12/2019
1	PotassiumIBA 12/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019
1	LipidsIBA 07/2015
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 07/2015
1	Insulin (Novolin)FDA Link 07/2015
1	Pioglitazone (Actos)FDA Link 11/2014
1	hydrochlorothiazide drug combination amilorideIBA 01/2004
1	1,4-dihydropyridine (dihydropyridine)IBA 01/2004
1	Nifedipine (Adalat)FDA LinkGeneric 01/2004
1	DiureticsIBA 01/2004
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2004
1	Indapamide FDA LinkGeneric 05/2003
1	Enalapril FDA LinkGeneric 05/2003
1	AlbuminsIBA 05/2003
1	perindopril drug combination indapamideIBA 05/2003
1	BradykininIBA 01/2003
1	Substance PIBA 01/2003
1	eprosartan (Teveten)FDA Link 01/2003
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2002
1	Angiotensin IIIBA 03/2002
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2002
1	Type 1 Angiotensin ReceptorIBA 01/2000

Therapy/Procedure

9	Denervation 12/2023 - 05/2012
7	Therapeutics 01/2020 - 01/2007
2	Peritoneal Dialysis 04/2017 - 01/2017
1	Renal Dialysis (Hemodialysis) 01/2017
1	Secondary Prevention 01/2017
1	Duration of Therapy 07/2015
1	Radiofrequency Ablation 08/2013
1	Catheters 05/2012